MiNK Therapeutics, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
INKT on Nasdaq
Location
149 Fifth Avenue, Suite 500, New York, NY

There are no Buy or Sell transactions made by insiders since 11/5/2023

MiNK Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Agenus Inc 10%+ Owner $22.6M Oct 12, 2023
Garo H. Armen Director $2.05M May 5, 2023
Brian Corvese Director $332K Sep 3, 2024
Ulf WIInberg Director $330K Sep 3, 2024
Jennifer Buell Chief Executive Officer $241K Jan 18, 2024
Barbara Ryan Director $103K Sep 3, 2024
Peter Behner Director $89.6K Sep 3, 2024
Christine Klaskin Treasurer $57.9K Oct 13, 2021
John Baldoni Director $42.8K Sep 1, 2023
Antonius van Dijk Chief Scientific Officer Jan 16, 2024
Walter Md Flamenbaum Director Oct 13, 2021

Recent Insider Transactions by Companies or Individuals for MiNK Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.